These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3917561)

  • 1. Standardization in VPA-induced hyperammonemia.
    Zaret BS; Marini AM
    Neurology; 1985 Jan; 35(1):136-7. PubMed ID: 3917561
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
    Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
    Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperammonemia in valproate therapy in children and adolescents].
    Laub MC
    Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid and secondary hyperammonemia.
    Rawat S; Borkowski WJ; Swick HM
    Neurology; 1981 Sep; 31(9):1173-4. PubMed ID: 6791053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperammonemia following intravenous valproate loading.
    DeWolfe JL; Knowlton RC; Beasley MT; Cofield S; Faught E; Limdi NA
    Epilepsy Res; 2009 Jul; 85(1):65-71. PubMed ID: 19299111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of hyperammonemia in stuporous states induced by sodium valproate].
    Warter JM; Marescaux C; Rumbach L; Micheletti G; Chabrier G; Koehl C; Imler M; Collard M
    Rev Neurol (Paris); 1983; 139(12):753-7. PubMed ID: 6420866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gait instability in valproate-treated patients: Call to measure ammonia levels.
    Kipervasser S; Elger CE; Korczyn AD; Nass RD; Quesada CM; Neufeld MY
    Acta Neurol Scand; 2017 Nov; 136(5):401-406. PubMed ID: 28436001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction.
    Zaret BS; Beckner RR; Marini AM; Wagle W; Passarelli C
    Neurology; 1982 Feb; 32(2):206-8. PubMed ID: 6798491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced hyperammonemia.
    Batshaw ML; Brusilow SW
    Ann Neurol; 1982 Mar; 11(3):319-21. PubMed ID: 6807193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic and renal contributions to valproic acid-induced hyperammonemia.
    Marini AM; Zaret BS; Beckner RR
    Neurology; 1988 Mar; 38(3):365-71. PubMed ID: 3126407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperammonemia and asterixis with valproic acid.
    Coulter D
    Neurology; 1981 Dec; 31(12):1580. PubMed ID: 6796907
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures.
    Gal P; Oles KS; Gilman JT; Weaver R
    Neurology; 1988 Mar; 38(3):467-71. PubMed ID: 3126410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute changes of blood ammonia may predict short-term adverse effects of valproic acid.
    Zaccara G; Campostrini R; Paganini M; Moroni F; Valenza T; Targioni G; Arnetoli G; Zappoli R; Baruzzi A
    Neurology; 1984 Nov; 34(11):1519-21. PubMed ID: 6436733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nondosage-dependent valproic acid-induced hyperammonemia and coma.
    Gaskins JD; Holt RJ; Postelnick M
    Clin Pharm; 1984; 3(3):313-6. PubMed ID: 6428801
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproate-induced coma: case report and literature review.
    Duarte J; Macias S; Coria F; Fernandez E; Clavería LE
    Ann Pharmacother; 1993 May; 27(5):582-3. PubMed ID: 8347908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine for valproic acid-induced hyperammonemia.
    Raby WN
    Am J Psychiatry; 1997 Aug; 154(8):1168-9. PubMed ID: 9247410
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperammonemia with valproic acid therapy.
    Coulter DL; Allen RJ
    J Pediatr; 1981 Aug; 99(2):317-9. PubMed ID: 6788925
    [No Abstract]   [Full Text] [Related]  

  • 19. A mechanism for valproate-induced hyperammonemia.
    Coude FX; Rabier D; Cathelineau L; Grimber G; Parvy P; Kamoun PP
    Pediatr Res; 1981 Jun; 15(6):974-5. PubMed ID: 6787550
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproic acid-induced hyperammonemia in mentally retarded adults.
    Williams CA; Tiefenbach S; McReynolds JW
    Neurology; 1984 Apr; 34(4):550-3. PubMed ID: 6422325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.